Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 77
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
Clin Infect Dis ; 74(6): 1112-1116, 2022 03 23.
Artículo en Inglés | MEDLINE | ID: mdl-34270715

RESUMEN

Whereas randomized clinical trials remain the gold standard for evaluating new therapies for infections, we argue that registries and observational studies early in the coronavirus disease 2019 (COVID-19) pandemic provided invaluable understanding of the natural history and preliminary data on risk factors and possible treatments. We review the data from the current pandemic, the history of registries in general, and their value in public health emergencies. Lessons from these experiences should be incorporated into rigorous planning for the next pandemic.


Asunto(s)
COVID-19 , Pandemias , Humanos , Salud Pública , Sistema de Registros , SARS-CoV-2
3.
Clin Infect Dis ; 73(8): 1327-1329, 2021 10 20.
Artículo en Inglés | MEDLINE | ID: mdl-34379735

RESUMEN

Clinical trials of severe sepsis that target crude mortality are underpowered to detect mortality differences due to intervention. We discuss the importance of including subcomponents of crude mortality in study design; how the proportion of attributable mortality affects sample size requirements; and how minor changes from predicted outcomes affect interpretation.


Asunto(s)
Sepsis , Mortalidad Hospitalaria , Humanos , Proyectos de Investigación , Tamaño de la Muestra
6.
Clin Infect Dis ; 2024 Mar 07.
Artículo en Inglés | MEDLINE | ID: mdl-38451287
9.
J Clin Apher ; 32(6): 567-570, 2017 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-27709659

RESUMEN

HIV complicates the diagnostic and therapeutic approaches to idiopathic thrombotic thrombocytopenic purpura (TTP), prompting debate in the literature regarding the benefit of plasma exchange versus simple plasma infusion. Herein we present a case of HIV-TTP, initially treated conservatively with plasma infusion but because of progressive neurologic decline, required urgent plasma exchange for resolution of hematologic derangements and neurologic sequelae. Based on the available literature, there appears to be a spectrum of HIV-associated TTP disorders. Patients with advanced HIV disease and opportunistic infections who present with thrombotic microangiopathy tend to respond to simple plasma infusion, while patients with less progressive HIV disease tend to behave like those with idiopathic TTP, requiring plasma exchange rather than simple plasma infusion. This article illustrates that in patients with HIV-TTP who do not respond to plasma infusion, early escalation to plasma exchange may help avoid life-threatening complications such as seizures and even death.


Asunto(s)
Infecciones por VIH , Intercambio Plasmático/métodos , Púrpura Trombocitopénica Trombótica/terapia , Púrpura Trombocitopénica Trombótica/virología , Adulto , Femenino , Humanos , Plasma , Púrpura Trombocitopénica Trombótica/complicaciones
12.
Infection ; 43(2): 141-4, 2015 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-25690849

RESUMEN

The American public entrusts academic medicine with a varied portfolio of critical responsibilities: the thoughtful mentoring of future generations of doctors, the engagement of cutting edge discoveries, and the empathic treatment of patients with complicated illnesses. The erosion of time to perform these duties has led to an estrangement of our key professional values and thus a loss of public trust, the inability to recognize new diseases, reduced communication in our ranks, and physician dissatisfaction. Much of this is driven by an unbalanced focus on the business model of medicine, highlighting rapid patient transactions linked to professional income with financial incentives for high-volume care. Reversing the current trends requires a new type of leadership committed to long-held professional values and a recognition of what drives professional excellence. As internists and infectious diseases specialists without procedures in our practice, we are especially vulnerable to these trends.


Asunto(s)
Academias e Institutos/normas , Medicina/normas , Comunicación , Humanos , Satisfacción en el Trabajo , Liderazgo , Médicos/normas , Opinión Pública
14.
J Biotechnol Biomed ; 6(3): 392-400, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-38745997

RESUMEN

The COVID-19 pandemic surge has exceeded testing capacities in many parts of the world. We investigated the effectiveness of home temperature monitoring for early identification of COVID-19 patients. Study Design ­: We compared home temperature measurements from a convenience sample of 1180 individuals who reported being test positive for SARS-CoV-2 to an age, sex, and location matched control group of 1249 individuals who had not tested positive. Methods ­: All individuals monitored their temperature at home using an electronic smartphone thermometer that relayed temperature measurements and symptoms to a centralized cloud based, de-identified data bank. Results -: Individuals varied in the number of times they monitored their temperature. When temperature was monitored for over 72 hours fever (≥ 37.6°C or 99.7°F or a change in temperature of ≥ 1°C or 1.8°F) was detected in 73% of test positive individuals, a sensitivity comparable to rapid SARS-CoV-2 antigen tests. When compared to our control group the specificity of fever for COVID-19 was 0.70. However, when fever was combined with complaints of loss of taste and smell, difficulty breathing, fatigue, chills, diarrhea, or stuffy nose the odds ratio of having COVID-19 was sufficiently high as to obviate the need to employ RTPCR or antigen testing to screen for and isolate coronavirus infected cases. Conclusions -: Our findings suggest that home temperature monitoring could serve as an inexpensive convenient screen for the onset of COVID-19, encourage earlier isolation of potentially infected individuals, and more effectively reduce the spread of infection in closed spaces.

19.
Infect Control Hosp Epidemiol ; 42(4): 399-405, 2021 04.
Artículo en Inglés | MEDLINE | ID: mdl-32928319

RESUMEN

OBJECTIVE: To determine risk factors for mortality among COVID-19 patients admitted to a system of community hospitals in the United States. DESIGN: Retrospective analysis of patient data collected from the routine care of COVID-19 patients. SETTING: System of >180 acute-care facilities in the United States. PARTICIPANTS: All admitted patients with positive identification of COVID-19 and a documented discharge as of May 12, 2020. METHODS: Determination of demographic characteristics, vital signs at admission, patient comorbidities and recorded discharge disposition in this population to construct a logistic regression estimating the odds of mortality, particular for those patients characterized as not being critically ill at admission. RESULTS: In total, 6,180 COVID-19+ patients were identified as of May 12, 2020. Most COVID-19+ patients (4,808, 77.8%) were admitted directly to a medical-surgical unit with no documented critical care or mechanical ventilation within 8 hours of admission. After adjusting for demographic characteristics, comorbidities, and vital signs at admission in this subgroup, the largest driver of the odds of mortality was patient age (OR, 1.07; 95% CI, 1.06-1.08; P < .001). Decreased oxygen saturation at admission was associated with increased odds of mortality (OR, 1.09; 95% CI, 1.06-1.12; P < .001) as was diabetes (OR, 1.57; 95% CI, 1.21-2.03; P < .001). CONCLUSIONS: The identification of factors observable at admission that are associated with mortality in COVID-19 patients who are initially admitted to non-critical care units may help care providers, hospital epidemiologists, and hospital safety experts better plan for the care of these patients.


Asunto(s)
COVID-19/patología , Signos Vitales , Factores de Edad , Anciano , Anciano de 80 o más Años , COVID-19/mortalidad , Femenino , Humanos , Modelos Logísticos , Masculino , Persona de Mediana Edad , Oxígeno/sangre , Admisión del Paciente/estadística & datos numéricos , Estudios Retrospectivos , Factores de Riesgo , Estados Unidos/epidemiología
20.
Infect Control Hosp Epidemiol ; 42(2): 228-229, 2021 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-33040751

RESUMEN

Coronavirus disease 2019 (COVID-19) has migrated to regions that were initially spared, and it is likely that different populations are currently at risk for illness. Herein, we present our observations of the change in characteristics and resource use of COVID-19 patients over time in a national system of community hospitals to help inform those managing surge planning, operational management, and future policy decisions.


Asunto(s)
COVID-19/epidemiología , COVID-19/terapia , Hospitalización/estadística & datos numéricos , Adulto , Factores de Edad , Anciano , Anciano de 80 o más Años , COVID-19/etnología , COVID-19/mortalidad , Femenino , Hispánicos o Latinos/estadística & datos numéricos , Hospitales Comunitarios , Humanos , Masculino , Persona de Mediana Edad , SARS-CoV-2/aislamiento & purificación , Virginia/epidemiología , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA